CARsgen begins phase II trial of CAR-T therapy in China

CARsgen Therapeutics, a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies...

March 24, 2022 | Thursday | News
VivaVision Biotech announces positive results of phase 2 study for treatment of dry eye disease

VivaVision Biotech, Inc. (VivaVision), an ophthalmic pharmaceutical developer focusing on discovery and development of i...

March 23, 2022 | Wednesday | News
China approves first thermal vapour energy system for COPD treatment

Broncus has announced that the company's thermal vapour treatment system InterVapor has been granted approval by the Nat...

March 22, 2022 | Tuesday | News
Transcenta partners with BMS

Transcenta Holding Limited, a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, ...

March 22, 2022 | Tuesday | News
OBiO Technology announces IPO

OBiO Technology has completed its initial public offering ("IPO") process and started trading on the Shanghai Stock...

March 22, 2022 | Tuesday | News
Bavarian Nordic partners with Nuance Pharma for RSV Vaccine in Asian markets

Denmark's Bavarian Nordic has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-base...

March 21, 2022 | Monday | News
Zai Labs appoints Josh Smiley as Chief Operating Officer

China-based Zai Lab Limited has announced the appointment of Josh Smiley as its Chief Operating Officer (COO). Smiley br...

March 21, 2022 | Monday | News
China's Triastek and Siemens to accelerate digital transformation of pharma industry

Triastek, Inc. and Siemens Ltd., China have signed a strategic collaboration agreement to provide digital tech...

March 18, 2022 | Friday | News
HitGen partners with Howard Hughes Medical Institute and Duke University

HitGen has entered into a research collaboration agreement with Howard Hughes Medical Institute ("HHMI") and Duke Univer...

March 18, 2022 | Friday | News
HiRO raised Tens of Millions of US Dollars in Series A Financing

Harvest Integrated Research Organization (HiRO) has announced the completion of its Series A financing in the tens of mi...

March 18, 2022 | Friday | News
Lynk Pharmaceuticals and Simcere partner for novel JAK1 inhibitor LNK01001

Lynk Pharmaceuticals and Simcere announced a strategic partnership to develop and commercialize a highly selective JAK1 ...

March 18, 2022 | Friday | News
China's SyMap targets renal denervation with novel 'map-and-ablate' technology

SyMap Medical is developing a selective map-and-ablate technology that has the potential to substantially improve outcom...

March 17, 2022 | Thursday | News
Ping An Good Doctor reports revenue of RMB7,334 Million in 2021

Ping An Healthcare and Technology Company Limited (Ping An Good Doctor) has announced its 2021 annual results. During th...

March 16, 2022 | Wednesday | News
Emerging Trends in Biopharma Deal-Making

Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, ...

March 15, 2022 | Tuesday | News
Adlai Nortye appoints Dr. Victoria Demby as Sr. VP of Global Regulatory Affairs

Adlai Nortye Ltd., a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies,...

March 15, 2022 | Tuesday | News
Chinese startup MediLink Therapeutics closes $70 M Series B financing

MediLink Therapeutics (Suzhou) Co., Ltd (MediLink) has announced completion of a $70million Series B financing. Thi...

March 15, 2022 | Tuesday | News
G-NiiB launches the world’s first anti-viral Gut Microbiome formula in Singapore

GenieBiome (G-NiiB), a biotechnology spin-off of The Chinese University of Hong Kong (CUHK), announces the launch of G-N...

March 15, 2022 | Tuesday | News
China fights against COVID-19 with traditional medicine and comprehensive care

Hong Kong Baptist University (HKBU) has established a transdisciplinary team of experts and supporting personnel to...

March 14, 2022 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls